Biotechnology FDA Mandates “Boxed Warning” For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies – Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY) Read more
Opinion Biotech Innovations Paving the Way in Breast Cancer Fight – AstraZeneca (NASDAQ:AZN), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Why Is Cancer Focused Xilio Therapeutics Stock Trading Higher On Thursday? – Xilio Therapeutics (NASDAQ:XLO), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Gilead’s Aggressive Push Beyond HIV Treatments – Plans To Increase Cancer-Focused CAR-T Treatment Production – Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead’s and Merck’s Combo Therapy – Merck & Co (NYSE:MRK), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges – Gilead Sciences (NASDAQ:GILD), GSK (NYSE:GSK) Read more
Biotechnology Why Is Gilead Sciences Stock Trading Lower Today? – Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst – CymaBay Therapeutics (NASDAQ:CBAY), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Why Is CymaBay Therapeutics Stock Trading Higher Today? – CymaBay Therapeutics (NASDAQ:CBAY), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are the Choices for Treatment? – Nanoviricides (AMEX:NNVC), Gilead Sciences (NASDAQ:GILD) Read more
